Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
XENOVIEW (XENON XE-129 HYPERPOLARIZED) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
XENOVIEW
NDA
Get alerts
XENON XE-129 HYPERPOLARIZED | N214375 | POLAREAN INC
1 strength
2 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Approvals
Label
Products
Patent Timeline
2 unique patents, 1 exclusivity by expiration date
Active (2)
Today
Exclusivity
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
Today
10583205
Feb. 20, 2035
11052161
Dec. 29, 2035
NCE
Dec. 23, 2027
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — N/A
RLD
2 patents
1 exclusivity
▴
GAS;INHALATION | Approved: Dec 23, 2022
Patents (2)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
10583205
Feb 20, 2035
—
—
Yes
—
—
11052161
Dec 29, 2035
—
—
Yes
—
—
Exclusivities (1)
Code
Date
Status
NCE
Dec 23, 2027
Active